Ignite Creation Date:
2024-05-05 @ 11:08 AM
Last Modification Date:
2024-10-26 @ 9:02 AM
Study NCT ID:
NCT00002034
Status:
COMPLETED
Last Update Posted:
2005-06-24
First Post:
1999-11-02
Brief Title:
A Study of the Safety and Tolerance of Long-Term Therapy With Intravenous Cytovene Ganciclovir Sodium for Cytomegalovirus Retinitis in Persons With AIDS
Sponsor:
Hoffmann-La Roche
Organization:
NIH AIDS Clinical Trials Information Service
Study Overview
Official Title:
A Study of the Safety and Tolerance of Long-Term Therapy With Intravenous Cytovene Ganciclovir Sodium for Cytomegalovirus Retinitis in Persons With AIDS
Status:
COMPLETED
Status Verified Date:
1992-01
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
To evaluate the safety and tolerance of long-term ganciclovir DHPG therapy for newly diagnosed macular threatening Cytomegalovirus CMV retinitis in AIDS patients To evaluate the clinical response to a 52 week course of intravenous DHPG therapy To evaluate the safety and tolerance of long-term DHPG with concurrent treatment with zidovudine AZT Patients utilizing treatment with other anti-retroviral drugs will be considered for study entry on a case by case basis To determine survival in this group of patients with AIDS and CMV retinitis
Detailed Description:
None
Study Oversight
Has Oversight DMC:
Is a FDA Regulated Drug?:
Is a FDA Regulated Device?:
Is an Unapproved Device?:
Is a PPSD?:
Is a US Export?:
Is an FDA AA801 Violation?:
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| ICM 1692 | None | None | None |